Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Mehroz Ehsan, a DPhil student working with Katja Gehmlich and Charles Redwood, and Matthew Kelly, a postdoc working with Houman Ashrafian and Hugh Watkins, have used a newly-generated mouse model to study the consequences of Muscle LIM protein mutations leading to Hypertrophic Cardiomyopathy.

The work, which is a collaboration with scientists at King's College London and the University of California San Diego, has shed light into disease mechanisms: protein depletion leads to lack of functional Muscle LIM protein and induces a proteotoxic response in the heart.

The research was led by Katja Gehmlich, BHF Intermediate Fellow in the Division of Cardiovascular Medicine and also involved collaborators at the Wellcome Trust Centre for Human Genetics. The article can be accessed here.

Similar stories

Having a healthier heart associated with better problem-solving and reaction time

People with healthier heart structure and function appear to have better cognitive abilities, including increased capacity to solve logic problems and faster reaction times, according to a study involving University of Oxford and Queen Mary University of London (QMUL) researchers.

Study provides new insights into causal mechanisms for atrial fibrillation

A large-scale genetic study, led by Oxford BHF researchers Dr Parag Gajendragadkar, clinical DPhil student, Professor Barbara Casadei and Professor Jemma Hopewell, has shed new light on common heart rhythm disturbances

New target identified to develop treatment for Abdominal Aortic Aneurysm

A new study from the Smart group has shed light on a key regulatory step in the initiation and progression of Abdominal Aortic Aneurysm by revealing the protective role of a previously little known small protein.

New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy

New research led by Oxford BHF CRE Intermediate Transition Fellow Dr Kerstin Timm shows that a recently developed imaging technique pioneered by the Tyler Group can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.

Bone hormone could provide new treatment for heart rhythm disorder

A hormone which helps regulate bone mass is also produced by the heart and could help treat people with a dangerous heart rhythm disorder, according to a new study published in the journal Nature.

New study enables identification of people at particular risk of rare, but serious, muscle-related side effect of statin therapy

Researchers at the Nuffield Department of Population Health, in collaboration with other researchers, have published new findings that identify a combination of factors that put some patients at higher risk of myopathy.